DocGo Inc. (DCGO)
USD 2.31
(5.0%)
USD 2.31
(5.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 6.85 Million USD | -80.17% |
| 2022 | 34.58 Million USD | 45.66% |
| 2021 | 23.74 Million USD | 260.44% |
| 2020 | -14.79 Million USD | 30.32% |
| 2019 | -21.23 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 6.52 Million USD | -41.84% |
| 2024 Q1 | 11.22 Million USD | 48.31% |
| 2023 FY | 6.85 Million USD | -80.17% |
| 2023 Q2 | -2.01 Million USD | 41.97% |
| 2023 Q4 | 7.57 Million USD | 58.88% |
| 2023 Q1 | -3.46 Million USD | -142.97% |
| 2023 Q3 | 4.76 Million USD | 336.91% |
| 2022 Q2 | 12.73 Million USD | 19.81% |
| 2022 Q1 | 10.62 Million USD | -54.88% |
| 2022 FY | 34.58 Million USD | 45.66% |
| 2022 Q4 | 8.06 Million USD | 226.97% |
| 2022 Q3 | 2.46 Million USD | -80.63% |
| 2021 Q1 | -1.67 Million USD | 62.64% |
| 2021 Q4 | 23.56 Million USD | 571.72% |
| 2021 Q3 | 3.5 Million USD | 313.07% |
| 2021 Q2 | -1.64 Million USD | 1.92% |
| 2021 FY | 23.74 Million USD | 260.44% |
| 2020 Q2 | -2.04 Million USD | 66.09% |
| 2020 Q1 | -6.03 Million USD | 0.0% |
| 2020 Q4 | -4.49 Million USD | -87.3% |
| 2020 FY | -14.79 Million USD | 30.32% |
| 2020 Q3 | -2.39 Million USD | -17.15% |
| 2019 FY | -21.23 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 131.654% |
| Addus HomeCare Corporation | 62.51 Million USD | 89.029% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | 253.125% |
| Amedisys, Inc. | -9.74 Million USD | 170.365% |
| Astrana Health, Inc. | 60.71 Million USD | 88.704% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 105.098% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 3.31 Million USD | -106.829% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 172.03% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 90.557% |
| COMPASS Pathways plc | -118.46 Million USD | 105.789% |
| The Ensign Group, Inc. | 209.39 Million USD | 96.725% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 82.133% |
| InnovAge Holding Corp. | -21.33 Million USD | 132.142% |
| The Joint Corp. | -9.75 Million USD | 170.327% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 103.682% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 143.957% |
| ModivCare Inc. | -204.46 Million USD | 103.354% |
| NewGenIvf Group Limited | 130.19 Thousand USD | -5167.914% |
| Option Care Health, Inc. | 267.09 Million USD | 97.432% |
| P3 Health Partners Inc. | -57.77 Million USD | 111.871% |
| P3 Health Partners Inc. | -57.77 Million USD | 111.871% |
| The Pennant Group, Inc. | 13.37 Million USD | 48.737% |
| Surgery Partners, Inc. | -11.9 Million USD | 157.634% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | 333.412% |
| Talkspace, Inc. | -19.18 Million USD | 135.755% |
| Talkspace, Inc. | -19.18 Million USD | 135.755% |
| The Oncology Institute, Inc. | -83.06 Million USD | 108.256% |
| The Oncology Institute, Inc. | -83.06 Million USD | 108.256% |